Intellectual Property UK

  • April 05, 2024

    Counterfeiters Flourish In Wake Of COVID, IP Body Says

    The COVID-19 pandemic resulted in a global uptick in the trade of counterfeit goods, beginning with fake healthcare products but spreading to other areas of trade as virtually all shopping moved online, a new report found Friday.

  • April 05, 2024

    3 Questions For Mishcon's David Rose And Jeremy Hertzog

    Clients look for many skills in intellectual property lawyers, but scientific expertise is not necessarily one of them, according to David Rose of Mishcon de Reya. Here, Rose and his colleague Jeremy Hertzog talk IP with Law360.

  • April 04, 2024

    Getty Says Stability AI Plays 'Active Role' In Making AI Images

    Stock images giant Getty Images has clapped back at the makers of the popular Stable Diffusion software in the companies' U.K. copyright dispute, saying Stability AI cannot claim that any potentially infringing image the generative AI model creates is due to the user's input alone.

  • April 04, 2024

    Henkel Loses Bid To Sweep Away Rival's Cleaning TM

    A Romanian cleaning product company has won its trademark appeal for its "Clinium" logo, after a European appellate board found that buyers would not conflate the sign with German rival Henkel's "Clin" trademark.

  • April 04, 2024

    Juul Can't Dodge UPC Vape Feud Over Rival's Admin Error

    Juul can't dash a challenge to five of its vaping patents even though its rival NJOY listed the wrong company in its initial papers, an appeals panel has said, giving the competing company the green light to tweak its claim.

  • April 04, 2024

    Velcro-Selling Co. Sues Rival Over Amazon Complaints

    A Northern Irish Velcro product distributor has accused a rival of spreading false rumors about its goods and putting the company in Amazon's bad books by returning several purchases and claiming they were "inauthentic."

  • April 04, 2024

    Gambling Biz Says Rival, Ex-Employees Copied Game Code

    An online gambling company has sued two former members of staff and its rival for allegedly plagiarizing copyrighted source code for its "Slingo" online betting game to produce several competing products.

  • April 03, 2024

    Genmab Builds Oncology Portfolio With $1.8B Deal

    Danish biotechnology company Genmab announced Wednesday that it would acquire private cancer drugmaker ProfoundBio for $1.8 billion in cash, a move set to beef up Genmab's oncology portfolio and position the company as a competitor to other biotech companies that have made similar deals in the antibody drug conjugate space in recent months.

  • April 03, 2024

    Jacob & Co. Can't Get TM Over Name For Alcohol Venture

    High-end jeweler Jacob & Co. can't register a trademark of its name over spirits after European officials ruled that a German company selling "Jacobi"-branded spirits had already established a presence in the market.

  • April 03, 2024

    IP Firm Reddie & Grose Names New Chairman, Eyes Growth

    Intellectual property boutique Reddie & Grose LLP has appointed Steve Howe as its next chairman, one of a series of senior promotions the business has made as it continues its growth push in the U.K. and Europe.

  • April 03, 2024

    EUIPO Director Seeks Clarity On TM Rules, In An Office First

    The executive director of the European Union's Intellectual Property Office has for the first time asked the office's Grand Board to clarify parts of the bloc's trademark rules, seeking guidance on when an EU-wide application can be converted into national requests.

  • April 03, 2024

    Uber Loses Some European TM Protections For Its Name

    Ride-hailing giant Uber has failed to persuade the European Union that it should retain a suite of broad trademarks for its name, with the bloc's intellectual property body deciding to trim down protections for computer software and telecommunications.

  • April 03, 2024

    Valrhona's Bid For 3D Mold TM Melts At UKIPO

    Valrhona has failed to register a 3D oval-shaped trademark after the U.K. intellectual property office ruled that it was a common mold in the industry and consumers would not link the cocoa bean lookalike to the premium French chocolatier.

  • April 02, 2024

    L'Oreal Holds Off Competitor's Objections To Hair Dye Patent

    A Japanese cosmetics brand failed to foil a L'Oreal hair-dyeing patent after European officials ruled that the invention to even out color satisfied all requirements, even if it didn't specify minimum concentrations for certain ingredients.

  • April 02, 2024

    Molson Coors Blocks Stone Brewing TM In UK

    California's Stone Brewing Co. could not convince the U.K.'s Intellectual Property Office to register a trademark for its own name, after drinks rival Molson Coors argued that it could be confused with existing trademarks it owns for the word "Stones."

  • April 02, 2024

    Shell-Exxon Joint Venture Fends Off Fuel Additive IP Attack

    An Exxon Mobil and Shell joint venture has successfully fought off attempts by competitors to invalidate its patent for a diesel fuel additive, with a European Patent Office appeals board ruling that the additive was inventive enough for protection.

  • April 02, 2024

    Blur Drummer Leads Competition Challenge Over Royalties

    The drummer for an English rock band is leading a legal challenge on behalf of songwriters, claiming that a society that collects royalties for artists has been unfairly distributing cash, according to details published by the Competition Appeal Tribunal on Tuesday.

  • April 02, 2024

    ASOS Loses Appeal For Topshop TM In Europe

    Online retailer ASOS has lost a second bid for trademark protection over the fashion brand name Topshop, with the European intellectual property authority saying the name lacks any distinctive character and simply means "an excellent store."

  • March 28, 2024

    House Of Fraser Loses Bid To Broaden 'BIBA' EU Trademark

    House of Fraser can't broaden its "BIBA" trademark because consumers could confuse the sign with an earlier "BiBA" logo that appears on similar goods, a European Union appeals panel has ruled.

  • March 28, 2024

    British Biz Hits Back At Chinese Co. In LED Mask Design Fight

    A British businesswoman has hit back at a Chinese light-therapy device manufacturer's claim that she misused its designs for an LED mask and bib, telling a London court she was always the rightful owner of the designs.

  • March 28, 2024

    Questel Partners With AI Workflow Automation Software Maker

    Intellectual property software provider Questel has partnered with a workflow automation software maker to help IP lawyers automate more document-based tasks with artificial intelligence, according to statements from both companies.

  • March 28, 2024

    4 Questions For Bristows' Commercial IP Experts

    Bristows LLP intellectual property leaders Matthew Warren and Robert Burrows have seen much change in their decades of advising clients, but they say the pace has “increased significantly” in recent years. Here, they talk to Law360 about artificial intelligence, the latest developments in FRAND disputes and other trends in IP litigation.

  • March 28, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen investors target fraudsters who ran a fake film tax scheme, Barclays Bank sue privately owned Russian bank PJSC Sovcombank, easyGroup bring a trademark infringement claim against online casino TGI Entertainment for its "easybet" word sign, and a bioethanol fuel company hit high-profile individuals connected to the collapsed Elysian Fuels scheme. Here, Law360 looks at these and other new claims in the U.K.

  • March 28, 2024

    Locksmith Hits Back At Security Biz In Key Copy Patent Feud

    A locksmith service has denied infringing an Austrian security company's patent by cutting copies of a key design, telling a court it could not have known the key was patent-protected and saying that the patent is invalid either way.

  • March 27, 2024

    Bayer Can Briefly Stop Rivals Selling Patented Xarelto Dosage

    Bayer AG can briefly block its rivals from selling generic versions of anticoagulant Xarelto at its protected once-daily dosage while both sides await a ruling on the validity of the patent, a London court said on Wednesday.

Expert Analysis

  • UK Ruling Shows Global SEP Enforcement Dilemma

    Author Photo

    The U.K. Supreme Court's recent ruling that U.K. judges have the power to set extraterritorial licensing royalty rates for standard-essential patents highlights a problem with global patent enforcement coordination and efficiency that could potentially be solved through the Patent Cooperation Treaty, says Roya Ghafele at Oxfirst.

  • Time To Reassess Your Patent Cooperation Treaty Strategy

    Author Photo

    In light of the trends outlined in the World Intellectual Property Organization's recent annual Patent Cooperation Treaty review, applicants should make decisions on which international search authority to use based on immediate cost, total cost and quality, says Karam Saab at Kilpatrick.

  • German FRAND Decision May Shape Global SEP Landscape

    Author Photo

    The German high court's recent decision that patent owner Sisvel didn't breach its fair, reasonable and nondiscriminatory patent licensing obligations by refusing to grant Haier a license represents a shift in the standard-essential patent landscape in favor of SEP holders' enforcement freedom, say Erik Puknys and Michelle Rice at Finnegan.

  • Sustainable Food Progress May Close Global Regulatory Gap

    Author Photo

    As the need for sustainable food production grows, the European sector will likely align with less stringent U.S. regulatory standards, which will further enable U.S. companies to expand globally and lead to more sophisticated intellectual property strategies in all regions, say Jane Hollywood and Fiona Carter at CMS Legal.

  • Cos. Should Assess IP, Contractual Protections For Their AI

    Author Photo

    Companies should understand the three types of intellectual property protection for safeguarding proprietary artificial intelligence — which is crucial to fighting the pandemic — as well as tools for creating protections when statutory means fall short, say Lori Bennett at Aetion and attorneys at Mayer Brown.

  • Tips For Accelerating Patent Prosecution In China

    Author Photo

    In light of recent Chinese patent statistics showing at least eight to 10 months to first office action and an average of 22.7 months to final disposition from the date of filing, there are several strategies applicants may explore to speed through examination, say Aaron Wininger at Schwegman Lundberg and Lei Tan at Pujing Chemical.

  • Use Of AI To Treat COVID-19 Shows Novel Inventorship Issues

    Author Photo

    As technology and medical companies collaborate to deploy artificial intelligence to combat COVID-19, questions arise about how best to protect AI innovations as well as who should get credit as an inventor, say attorneys at Cadwalader.

  • Israel's Generic COVID-19 Drug Licensing Lacks Due Process

    Author Photo

    The Israel attorney general's special compulsory license for imported generic versions of Abbvie's patented antiviral drug Kaletra to treat COVID-19 does not provide a right of response, a hearing or direct judicial review, says Ephraim Heiliczer at Pearl Cohen.

  • New US Policy On SEP Remedies Restores Critical Balance

    Author Photo

    The new joint U.S. Department of Justice-U.S. Patent and Trademark Office policy on standard-essential patents, clarifying that injunctions are available in accordance with general remedies law, helps restore a power balance between technology innovators and users, and realigns U.S. patent law with other jurisdictions, say attorneys at McKool Smith.

  • Vaccine IP Under Microscope With Coronavirus Outbreak

    Author Photo

    The coronavirus global outbreak, which has focused attention on the role patent systems play in encouraging investment in vaccines and cures, affords an opportunity to examine the tension among patent rights, investments, governments and public health, say Gaby Longsworth and Robert Greene Sterne at Sterne Kessler.

  • EU Lacks Effective Tool For Resolving Border Disputes

    Author Photo

    The European Court of Justice recently found that it did not have jurisdiction over Slovenia's claim to enforce an arbitration award against Croatia, indicating that EU legal framework cannot be used to resolve intra-EU border disputes, and that a new mechanism should possibly be developed, says Akshay Sewlikar at Linklaters.

  • Rebuttal

    AI Can't Accurately Predict Case Length And Cost — Yet

    Author Photo

    A recent Law360 guest article argued that artificial intelligence can precisely estimate the length and cost of a new case, but several limitations will likely delay truly accurate predictions for years to come, says Andrew Russell at Shaw Keller.

  • Trade Agreements With EU Will Still Be Elusive Post-Brexit

    Author Photo

    Although a post-Brexit transitional arrangement largely preserves the status quo between the U.K. and the EU through the end of the year, intense trade negotiations for key industries are still to come, with the possibility of a no-deal exit in 2021, say attorneys at Baker Botts.

  • Surefire Marketing Methods To Build Your Legal Practice

    Author Photo

    Attorneys who take the time and the risk to showcase their talents through speaking, writing and teaching will find that opportunities will begin building upon themselves, says Daniel Karon of Karon LLC.

  • Some Clarity On Inventor-Employee Compensation In The UK

    Author Photo

    The recent U.K. Supreme Court decision in Shanks v. Unilver swept away a perception that some employers are simply too big to pay inventor compensation under the U.K.’s statutory compensation provisions, and may offer some hope to prospective employees, say attorneys at Haseltine Lake.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!